Corrections & Clarifications

Corrections and clarifications — July 14, 2021

A Business page story titled “Rubicon buys Cipla arm’s oral liquid, nasal product unit” (July 10, 2021) erroneously described Rubicon as a specialty pharmaceutical company backed by General Electric. It should have been General Atlantic.

Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Sep 26, 2021 1:15:28 PM |

Next Story